del Frate Chiara, Bazzocchi Massimo, Mortele Koenraad J, Zuiani Chiara, Londero Viviana, Como Giuseppe, Zanardi Romeo, Ros Pablo R
Institute of Radiology, Udine University, Policlinico Universitario a Gestione diretta, via Colugna 50, 33100 Udine, Italy.
Radiology. 2002 Dec;225(3):766-72. doi: 10.1148/radiol.2253011854.
To compare gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging with ferumoxides-enhanced MR imaging for detection of liver metastases.
Twenty consecutive patients known to have malignancy and suspected of having focal liver lesions at ultrasonography (US) underwent 1.0-T MR imaging with gradient-recalled-echo T1-weighted breath-hold sequences before, immediately after, and 60 minutes after Gd-BOPTA injection. Subsequently, MR imaging was performed with turbo spin-echo short inversion time inversion-recovery T2-weighted sequences before and 60 minutes after ferumoxides administration. All patients subsequently underwent intraoperative US within 15 days, and histopathologic analysis of their resected lesion-containing specimens was performed. Separate qualitative analyses were performed to assess lesion detection with each contrast agent. Quantitative analyses were performed by measuring signal-to-noise and contrast-to-noise ratios (CNRs) on pre- and postcontrast Gd-BOPTA and ferumoxides MR images. Statistical analyses were performed with Wilcoxon signed rank and Monte Carlo tests.
Sensitivity of ferumoxides-enhanced MR imaging was superior to that of Gd-BOPTA-enhanced MR imaging for liver metastasis detection (P <.05). Ferumoxides MR images depicted 36 (97%) of 37 metastases detected at intraoperative US, whereas Gd-BOPTA MR images depicted 30 (81%) metastases during delayed phase and 20 (54%) during dynamic phase. All six metastases identified only at ferumoxides-enhanced MR imaging were 5-10 mm in diameter. There was a significant increase in CNR between the lesion and liver before and after ferumoxides administration (from 3.8 to 6.8, P <.001) but not before or after Gd-BOPTA injection (from -4.8 to -5.5, P >.05).
Ferumoxides-enhanced MR imaging seems to be superior to Gd-BOPTA-enhanced MR imaging for liver metastasis detection.
比较钆贝葡胺(Gd - BOPTA)增强磁共振(MR)成像与超顺磁性氧化铁增强MR成像对肝转移瘤的检测效果。
连续20例已知患有恶性肿瘤且超声检查(US)怀疑有肝脏局灶性病变的患者,在注射Gd - BOPTA前、注射后即刻及注射后60分钟接受1.0 - T MR成像,采用梯度回波T1加权屏气序列。随后,在注射超顺磁性氧化铁前及注射后60分钟,采用快速自旋回波短反转时间反转恢复T2加权序列进行MR成像。所有患者随后在15天内接受术中超声检查,并对切除的含病变标本进行组织病理学分析。分别进行定性分析以评估每种造影剂对病变的检测情况。通过测量Gd - BOPTA和超顺磁性氧化铁MR成像对比剂注射前后的信噪比和对比噪声比(CNR)进行定量分析。采用Wilcoxon符号秩检验和蒙特卡罗检验进行统计学分析。
超顺磁性氧化铁增强MR成像检测肝转移瘤的敏感性优于Gd - BOPTA增强MR成像(P <.05)。术中超声检测到37个转移瘤,超顺磁性氧化铁MR图像显示其中36个(97%),而Gd - BOPTA MR图像在延迟期显示30个(81%)转移瘤,动态期显示20个(54%)。仅在超顺磁性氧化铁增强MR成像中发现的6个转移瘤直径均为5 - 10 mm。注射超顺磁性氧化铁前后病变与肝脏之间的CNR有显著增加(从3.8增至6.8,P <.001),而注射Gd - BOPTA前后无显著变化(从 - 4.8降至 - 5.5,P >.05)。
超顺磁性氧化铁增强MR成像在检测肝转移瘤方面似乎优于Gd - BOPTA增强MR成像。